Shanghai Boxun Medical Biological Instrument (BJSE:836504) EBIT : ¥22.4 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Shanghai Boxun Medical Biological Instrument EBIT?

Shanghai Boxun Medical Biological Instrument's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ¥4.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥22.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Shanghai Boxun Medical Biological Instrument's annualized ROC % for the quarter that ended in Sep. 2024 was 12.69%. Shanghai Boxun Medical Biological Instrument's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 23.32%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Shanghai Boxun Medical Biological Instrument's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 2.45%.

Shanghai Boxun Medical Biological Instrument EBIT Historical Data

The historical data trend for Shanghai Boxun Medical Biological Instrument's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Boxun Medical Biological Instrument EBIT Chart

Shanghai Boxun Medical Biological Instrument Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

16.26

24.83

31.96

30.39

30.50

Shanghai Boxun Medical Biological Instrument Quarterly Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT	Get a 7-Day Free Trial															4.71	12.86	1.58	3.04	4.88

Competitive Comparison of Shanghai Boxun Medical Biological Instrument's EBIT

For the Medical Instruments & Supplies subindustry, Shanghai Boxun Medical Biological Instrument's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Boxun Medical Biological Instrument's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai Boxun Medical Biological Instrument's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shanghai Boxun Medical Biological Instrument's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Shanghai Boxun Medical Biological Instrument EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥22.4 Mil.

Shanghai Boxun Medical Biological Instrument (BJSE:836504) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Shanghai Boxun Medical Biological Instrument's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	19.264 * ( 1 - 10.25% )	/	( (138.331	+	134.158)	/ 2 )
=	17.28944	/	136.2445
=	12.69 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	247.452	-	22.931	-	( 86.19	-	max(0, 38.364	-	154.094	+	86.19	))
=	138.331

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	257.709	-	24.011	-	( 99.54	-	max(0, 44.248	-	184.697	+	99.54	))
=	134.158

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Shanghai Boxun Medical Biological Instrument's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	19.516	/	( ( (42.304 + max(36.916, 0))	+	(42.398 + max(45.725, 0)) )	/	2 )
=	19.516	/	( ( 79.22	+	88.123 )	/	2 )
=	19.516	/	83.6715
=	23.32 %

where Working Capital is:

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(26.701	+	30.614	+	5.962)	-	(22.931	+	0	+	3.43)
=	36.916

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(22.144	+	28.919	+	26.907)	-	(24.011	+	0	+	8.234)
=	45.725

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Shanghai Boxun Medical Biological Instrument's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	22.359	/	912.032
	=	2.45 %

Shanghai Boxun Medical Biological Instrument EBIT Related Terms

Thank you for viewing the detailed overview of Shanghai Boxun Medical Biological Instrument's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Boxun Medical Biological Instrument Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Boxun Medical Biological Instrument Corp (BJSE:836504) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 599 Zhongqiang Road, Maogang Town, Songjiang, Shanghai, CHN, 200071

Website

http://www.boxun.com.cn

Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products and purification safety series products, etc.

Shanghai Boxun Medical Biological Instrument Headlines

No Headlines